All Stories

‘America-first resurgence’: Amid market correction, biotech nears new era, PitchBook says

Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” according to a new report from PitchBook. Companies focused on AI integration and manufacturing innovation are expected to win out, according to the firm.

Apr 18, 2025 - 13:32
 0
‘America-first resurgence’: Amid market correction, biotech nears new era, PitchBook says
Biotechs will need to be strategic to achieve “tariff-era success” as the sector enters an “America-first resurgence,” according to a new report from PitchBook. Companies focused on AI integration and manufacturing innovation are expected to win out, according to the firm.
Read More

Tags:

Previous Article

At $37,900, Is This 2019 Mercedes E450 Convertible A Stylish Steal?

Next Article

U.S. judge finds Google guilty of ad tech monopoly, prompting industry-wide concern

Related Posts

Cyclacel Pharmaceuticals sheds clinical cancer asset in effort to stop cash spiral

Cyclacel Pharmaceuticals sheds clinical cancer asset in...

Apr 3, 2025  0

PacBio to cut headcount, costs in face of tariff headwinds

PacBio to cut headcount, costs in face of tariff headwinds

Apr 9, 2025  0

Vincerx's final merger attempt collapses, leaving ADC biotech to wind down

Vincerx's final merger attempt collapses, leaving ADC b...

Apr 9, 2025  0